Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Terns Pharmaceuticals Inc fell by 63.31m. Cash Flow from Financing totalled 41.95m or -- of revenues. In addition the company used 67.39m for operations while cash used for investing totalled 37.99m.
Cash flow per share | -1.17 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 4.29 |
---|---|
Tangible book value per share | 4.29 |
More ▼
Balance sheet in USDView more
Current ratio | 32.99 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼